Rang	Name	Position
1	Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.	Director & Principal Executive Officer
2	Mr. Charles A. Deignan	Principal Financial Officer & Principal Accounting Officer
3	Ms. Jenny R. Kobin	Head of Investor Relations
4	Mr. Rick McElheny	Senior Vice President of Corporate Development & Alliance Management
5	Mr. Rafael V. Andino	Senior Vice President of Engineering & Manufacturing

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	0,29%	0,01 Mio. USD
2	Carmignac Gestion	0,13%	0,00 Mio. USD
3	Geode Capital Management, LLC	0,07%	0,00 Mio. USD
4	BlackRock Inc	0,05%	0,00 Mio. USD
5	GSA Capital Partners LLP	0,05%	0,00 Mio. USD
6	Renaissance Technologies Corp	0,04%	0,00 Mio. USD
7	First Manhattan Co. LLC	0,03%	0,00 Mio. USD
8	State Street Corp	0,02%	0,00 Mio. USD
9	Bridgeway Capital Management, LLC	0,02%	0,00 Mio. USD
10	Northern Trust Corp	0,01%	0,00 Mio. USD
11	Assenagon Asset Management SA	0,01%	0,00 Mio. USD
12	Morgan Stanley - Brokerage Accounts	0,01%	0,00 Mio. USD
13	PNC Financial Services Group Inc	0,01%	0,00 Mio. USD
14	Brown Wealth Management, LLC	0,01%	0,00 Mio. USD
15	Northeast Financial Consultants, Inc	0,01%	0,00 Mio. USD
16	Susquehanna International Group, LLP	0,01%	0,00 Mio. USD
17	CapTrust Financial Advisors	0,01%	0,00 Mio. USD
18	Stifel Financial Corp	0,00%	0,00 Mio. USD
19	Investor's Fiduciary Advisor Network, LLC	0,00%	0,00 Mio. USD
20	UBS Group AG	0,00%	0,00 Mio. USD